ClinicalTrials.Veeva

Menu

Indicators of Inflammation and Coagulation in Sepsis

University of Oklahoma (OU) logo

University of Oklahoma (OU)

Status

Completed

Conditions

Sepsis

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

We will collect blood samples from patients with the diagnosis of sepsis and other ICU patients. We will describe the course of different mediator levels and organ injury markers and follow their progression throughout the course of the study.

Full description

After informed consent is obtained 5 cc of blood is collected on the day of admission and on days 0, 1, 3, and 7 thereafter. Plasma is collected and frozen for the subsequent measurement of biomarkers.

Enrollment

500 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Admission to the ICU

Exclusion criteria

  • No blood draws scheduled
  • Hemoglobin level < 6,5 gm/dl

Trial design

500 participants in 2 patient groups

Sepsis
Description:
Patients with severe sepsis
Non-infected
Description:
ICU patients without evidence of infection

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems